Dentistry Journal (Oct 2020)

Impact of Local Drug Delivery of Minocycline on the Subgingival Microbiota during Supportive Periodontal Therapy: A Randomized Controlled Pilot Study

  • Haruna Miyazawa,
  • Takako Nakajima,
  • Makoto Horimizu,
  • Kazuhiro Okuda,
  • Noriko Sugita,
  • Kyoko Yamazaki,
  • Lu Li,
  • Yoshiko Hayashi-Okada,
  • Takuya Arita,
  • Misa Nishimoto,
  • Mieko Nishida,
  • Robert J. Genco,
  • Kazuhisa Yamazaki

DOI
https://doi.org/10.3390/dj8040123
Journal volume & issue
Vol. 8, no. 4
p. 123

Abstract

Read online

The aim of this study was to examine the effect of adjunct local minocycline administration on the microbiological parameters of subgingival plaque samples in the residual periodontal pockets. Ten chronic periodontitis patients under a supportive periodontal therapy regimen were recruited. After subgingival debridement, either 2% minocycline gel, Periocline™, (Test Group) or a placebo (Control Group) was administered to the selected sites once a week for three weeks. Subgingival plaque was collected at baseline, and at four weeks and eight weeks. The microbiological composition was analyzed by 16S ribosomal RNA sequencing. In the Test Group, α-diversity (evenness) decreased compared to the baseline (p = 0.005) and was lower compared to the control group at four weeks (p = 0.003). The microbial community composition between the two groups was significantly different at four weeks (p = 0.029). These changes were attributable to a decrease in the bacteria associated with periodontitis and an increase in the bacteria associated with periodontal health. Additionally, the improvement in bleeding on probing continued at eight weeks; however, there were little microbial effects of 2% minocycline gel observed at eight weeks. The control group demonstrated no change throughout the eight-week experimental period. Thus, local minocycline administration can change the subgingival microbial community of residual periodontal pockets.

Keywords